Pages that link to "Q30437217"
Jump to navigation
Jump to search
The following pages link to Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine (Q30437217):
Displaying 50 items.
- Applications of urinary proteomics in biomarker discovery (Q27010368) (← links)
- A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy (Q28478586) (← links)
- Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study (Q28484968) (← links)
- Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products (Q28533986) (← links)
- Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease (Q30430034) (← links)
- Discovery and validation of urinary biomarkers for prostate cancer (Q30438582) (← links)
- Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments (Q30438814) (← links)
- Mass spectrometry based proteomics in urine biomarker discovery (Q30444285) (← links)
- Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications (Q31148183) (← links)
- Human body fluid proteome analysis (Q33262623) (← links)
- Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm (Q33436829) (← links)
- Biomarker analysis for prostate cancer diagnosis using LC-MS and CE-MS. (Q33451945) (← links)
- Approaching clinical proteomics: current state and future fields of application in fluid proteomics (Q33467523) (← links)
- High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine (Q33610197) (← links)
- Urine Peptidomics for Clinical Biomarker Discovery (Q33698379) (← links)
- Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria (Q33735287) (← links)
- Urinary proteomics as a novel tool for biomarker discovery in kidney diseases (Q33781011) (← links)
- Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease (Q34129628) (← links)
- Left ventricular diastolic function in relation to the urinary proteome: a proof-of-concept study in a general population (Q34140378) (← links)
- Investigation and reduction of sub-microgram peptide loss using molecular weight cut-off fractionation prior to mass spectrometric analysis (Q34423522) (← links)
- Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis (Q34503824) (← links)
- Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine (Q34691573) (← links)
- Current state of the art for enhancing urine biomarker discovery (Q36032361) (← links)
- Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction. (Q36053833) (← links)
- Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis (Q36089848) (← links)
- Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment (Q36171255) (← links)
- Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis (Q36279044) (← links)
- Capillary electrophoresis-mass spectrometry, an attractive tool for drug bioanalysis and biomarker discovery (Q36525889) (← links)
- Searching for the noninvasive biomarker holy grail: are urine proteomics the answer? (Q36601626) (← links)
- Urinary proteomics in diabetes and CKD (Q36736792) (← links)
- CE - a multifunctional application for clinical diagnosis (Q36788156) (← links)
- Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease (Q36837589) (← links)
- Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases (Q36874248) (← links)
- Biomarkers for prostate cancer (Q36906722) (← links)
- Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction (Q36993564) (← links)
- The present and future of prostate cancer urine biomarkers (Q37007392) (← links)
- CE at the omics level: towards systems biology--an update (Q37015597) (← links)
- Trends in CE-MS 2005-2006. (Q37045725) (← links)
- Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform (Q37050438) (← links)
- Urine in clinical proteomics (Q37230698) (← links)
- Advances in separation science applied to metabonomics (Q37292558) (← links)
- Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge (Q37365408) (← links)
- Electrolyte systems for on-line CE-MS: detection requirements and separation possibilities (Q37373501) (← links)
- The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease (Q37401369) (← links)
- Utility of mass spectrometry for proteome analysis: part II. Ion-activation methods, statistics, bioinformatics and annotation (Q37455170) (← links)
- Tomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis (Q37465366) (← links)
- Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective (Q37484011) (← links)
- Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery. (Q37644354) (← links)
- CE-MS and related techniques as a valuable tool in tumor biomarkers research. (Q37720614) (← links)
- CE-MS in biomarker discovery, validation, and clinical application (Q37833587) (← links)